Composur: Study to Understand the Performance of Vibegron in Participants With Overactive Bladder (OAB)
Status:
Not yet recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the treatment satisfaction, discontinuation, reasons for
discontinuation, quality of life, healthcare resource utilization, and safety with Vibegron
for the treatment of OAB in the context of real-world clinical practice.